Confirmatory Results
Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe
Mengfei Lu, View ORCID ProfileCathryn M. Lewis, View ORCID ProfileMatthew Traylor
doi: https://doi.org/10.1101/098541
Mengfei Lu
1Department of Medical and Molecular Genetics, King’s College London, 8th Floor Tower Wing, Guy’s Hospital, Great Maze Pond, London, SE1 9RT, UK
Cathryn M. Lewis
1Department of Medical and Molecular Genetics, King’s College London, 8th Floor Tower Wing, Guy’s Hospital, Great Maze Pond, London, SE1 9RT, UK
2SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, De Crespigny Park, Denmark Hill, London, SE5 8EF, UK
Matthew Traylor
1Department of Medical and Molecular Genetics, King’s College London, 8th Floor Tower Wing, Guy’s Hospital, Great Maze Pond, London, SE1 9RT, UK
Article usage
Posted January 05, 2017.
Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe
Mengfei Lu, Cathryn M. Lewis, Matthew Traylor
bioRxiv 098541; doi: https://doi.org/10.1101/098541
Subject Area
Subject Areas
- Biochemistry (11571)
- Bioengineering (8622)
- Bioinformatics (28868)
- Biophysics (14803)
- Cancer Biology (11941)
- Cell Biology (17168)
- Clinical Trials (138)
- Developmental Biology (9302)
- Ecology (14019)
- Epidemiology (2067)
- Evolutionary Biology (18128)
- Genetics (12145)
- Genomics (16616)
- Immunology (11707)
- Microbiology (27692)
- Molecular Biology (11387)
- Neuroscience (60096)
- Paleontology (447)
- Pathology (1847)
- Pharmacology and Toxicology (3184)
- Physiology (4878)
- Plant Biology (10278)
- Synthetic Biology (2849)
- Systems Biology (7289)
- Zoology (1619)